We also examined whether intravenous CRH administration increases ACTH and cortisol responses, exaggerates colonic motility, and alters sympathovagal balance in patients with IBS compared to healthy control subjects, taking into account the putative sex differences. This evidence concerns the gene POMC and irritable bowel syndrome.